---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-002106"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T06:33:04.719057+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# No material new facts identifiable in January 2025 corporate presentation

## Summary
- Presentation content not reproduced in the 8-K; only forward-looking language and boilerplate visible.
- No specific pipeline, financial, or clinical milestones disclosed in the filing excerpt.
- Event is a routine corporate presentation update; provides no directional signal for investors.
- Ticker ADIL referenced; no other counterparties or material events mentioned.

## SEC filing metadata
- accession: 0001213900-25-002106
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390025002106/0001213900-25-002106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025002106/ea0227224-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-002106
- JSON: https://secwatch.observer/filing/0001213900-25-002106.json
- Plain text: https://secwatch.observer/filing/0001213900-25-002106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.